Delivery Order 75N95018G00019-75N95019F00089
Award Date 8/1/19
Potential Completion Date 5/31/22
Potential Value $532K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a task order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to SRI International, a nonprofit research and development institute. The task order, titled "Whole Body Plethysmography in Rats," is for a period of performance from March 3, 2019 to March 4, 2020, with a potential value of $190,990.19. The task order is part of the "Toxicological Evaluations of Potential Medications" major program, and is issued as a...
- Sri International has been awarded a cost-plus-fixed-fee delivery order valued at $571,190 by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to conduct Task Order 01 for Cocaine Interaction Safety Studies in Rats under the Toxicological Evaluations of Potential Medications IDIQ. The ordering period is from September 12, 2023 through September 11, 2024. The place of performance is West Menlo Park, California. No set-aside designation...
- SRI International, a nonprofit research and development organization, was awarded a delivery order valued at $1.67M under the National Institute on Drug Abuse's (NIDA) indefinite delivery/indefinite quantity (IDIQ) contract HHSN271201800019I. Task Order 75N95022F00001, titled "GLP Interaction Safety Studies in Rats and Dogs," runs from November 17, 2021 through February 28, 2026 and focuses on toxicological evaluations of potential medications. The contract employs a...
- This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) to SRI International, a nonprofit research and development institute. The purpose of the contract is to conduct purpose interaction safety studies in rats and dogs, with a period of performance from March 25, 2020 to March 24, 2021. The total potential value of the contract is $1,206,338.00. The contract is part of...
- This is a task order award under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract with the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $2,909,141.00 task order is for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments" and has a completion date of May 19, 2022. The prime contractor is Sri International, a non-profit research institute that provides a...
- Sri International has been awarded Task Order 75N95020F00002 under the National Institute on Drug Abuse (NIDA) Indefinite Delivery/Indefinite Quantity (IDIQ) contract HHSN271201800019I to conduct Good Laboratory Practice (GLP) interaction safety studies in rats and dogs. This task order, valued at $1.2M, supports NIDA's broader program of toxicological evaluations of potential medications and was awarded on September 14, 2020, with a completion date of September 13, 2022. The work will be...
- This task order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to SRI International, a non-profit research institute, for an expanded study on acute toxicology for a radiotracer under the NIMH Toxicological Evaluation of Novel Ligands Program. The task order has a firm fixed price of $203,534 and a completion date of September 30, 2021. It is not designated as a set-aside contract. SRI International has...
- This federal contract award to SRI International, a non-profit research and development institute, is for $1,469,307.00 to conduct rodent and non-rodent pharmacokinetic studies. The contract is a delivery order issued under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master IDIQ contract with the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The...
- This is a $7,323,160.93 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS). The contract is for continuous rodent and non-rodent pharmacokinetic assessments under the Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ contract. The prime contractor is SRI International, a large non-profit research and development institute that frequently partners...
- This is a task order award under the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract held by Sri International, a nonprofit research and development institute. The task order, valued at $4,199,188, is for the National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services, to obtain toxicology services from Sri International. The task order has an ultimate...
- 75N95018G00019Basic Ordering Agreement
- 75N95018G00019-75N95019F00089Delivery Order
This task order was awarded by the National Institutes of Health (NIH), a component of the Department of Health and Human Services (HHS), to the non-profit research institute SRI International. The $531,805.00 task order is for interaction safety studies in rats using whole body plethysmography, supporting the NIH's National Institute on Drug Abuse's toxicological evaluations of potential medications program. The period of performance is from August 1, 2019 to July 31, 2020, with a current completion date of May 31, 2022. This task order is under a larger indefinite delivery vehicle (IDV) with SRI International, though details on the IDV were not provided. The contract does not utilize any set-aside provisions.
Generated 3/23/24, 1:01 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Toxicological Evaluations of Potential Medications | NIHDA201800011 | Department of Health and Human Services National Institutes of Health | Award Notice 2/2 | 2/9/18, 3:23 PM | |
Toxicological Evaluations of Potential Medications | NIHDA201800011 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/2 | 12/4/17, 10:42 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Change Order | $0 | 2/25/22 | |
| P00004 | Change Order | $0 | 11/16/21 | |
| P00003 | Change Order | $0 | 5/24/21 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 1/28/21 | |
| P00001 | Change Order | $12.0k | 7/7/20 |